The Valley Desk

NCT00240253 · Interventional trial

A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 Diabetes

Overall registry status Completed

Phase 4

Conditions Type 2 Diabetes Mellitus

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov